Thermo Fisher Scientific Inc (TMO) Earnings Call Analysis
NYSE · Healthcare · Diagnostics & Research
Earnings Reports
-
Thermo Fisher Scientific (TMO) Q2 2026: Analytical Instruments Margin Expands 420bps, Innovation-Driven Upside
July 24, 2026
-
Thermo Fisher Scientific (TMO) Q1 2026: Clario Adds $900M to Revenue Guide, Pharma Strength Offsets Academic Drag
April 23, 2026
-
Thermo Fisher (TMO) Q4 2025: $16.5B Deployed for M&A and Buybacks Sets Up 6–8% EPS Growth
January 29, 2026
-
Thermo Fisher (TMO) Q3 2025: Operating Margin Expands 100bps, AI and Onshoring Shape Growth Path
October 22, 2025
-
Thermo Fisher (TMO) Q2 2025: Cost Actions Add $300M, Margin Expansion Outpaces Tariff Drag
July 23, 2025
-
Thermo Fisher Scientific (TMO) Q1 2025: Navigates Tariff Volatility with Operational Discipline and Strategic Flexibility
June 10, 2025